A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants
SARS-CoV-2 has caused the COVID-19 pandemic since early 2020. As of January 2022, the worldwide spreading of SARS-CoV-2 leads to approximately 0.35 billion of human infections and five millions of deaths. Current vaccination is one of the effective ways to control SARS-CoV-2 transmission and reduce...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis Group
2022-12-01
|
| 叢編: | Emerging Microbes and Infections |
| 主題: | |
| 在線閱讀: | https://www.tandfonline.com/doi/10.1080/22221751.2022.2053365 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|